Impact Of Red And Processed Meat And Fibre Intake On Treatment Outcomes Among Patients With Chronic Inflammatory Diseases Protocol For A Prospective Cohort Study Of Prognostic Factors And Personalised Medicine

This research protocol outlines a large study examining how diet influences treatment outcomes for people with chronic inflammatory diseases. The researchers plan to follow 320 patients with conditions like inflammatory bowel disease (Crohn's disease and ulcerative colitis) and rheumatic disorders who are starting treatment with specialized medications called TNF inhibitors, which are biological drugs that reduce inflammation.

The study specifically focuses on three dietary factors: red meat consumption, processed meat intake, and fiber consumption. This research is important because up to one-third of patients don't respond well to these expensive biological treatments, and scientists suspect that lifestyle factors, particularly diet, may play a crucial role in determining treatment success. Currently, doctors have limited guidance on how dietary choices might help optimize treatment outcomes for their patients.

The researchers will track patients from June 2017 to March 2019, collecting detailed information about their eating habits and monitoring how well they respond to their anti-inflammatory medications. This type of research could eventually lead to personalized treatment approaches where doctors provide specific dietary recommendations alongside medical treatments to improve patient outcomes.

For metabolic health, this study represents an important step toward understanding how food choices directly impact inflammation and treatment response. The findings could help healthcare providers develop more comprehensive treatment plans that combine targeted medications with evidence-based dietary strategies, potentially improving outcomes while reducing healthcare costs and medication side effects.